A double dummy and double blind, multicenter, randomized study of the efficacy and safety of Seroquel (quetiapine fumarate) and lithium as monotherapy in the treatment of acute mania in patients with bipolar disorder

Trial Profile

A double dummy and double blind, multicenter, randomized study of the efficacy and safety of Seroquel (quetiapine fumarate) and lithium as monotherapy in the treatment of acute mania in patients with bipolar disorder

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Lithium; Quetiapine
  • Indications Bipolar disorders
  • Focus Therapeutic Use
  • Acronyms STAR
  • Sponsors AstraZeneca
  • Most Recent Events

    • 07 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top